US Patent 10149847 Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
All edits
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+173 characters)
Article
Patent abstract
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure:
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
John S. Kovach0
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 3 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 23 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10149847 Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
Infobox
Is a
Patent jurisdiction
Patent number
10149847
Date of patent
December 11, 2018
Patent application number
14408475
Date Filed
June 28, 2013
Patent primary examiner
Find more entities like US Patent 10149847 Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
